Practical Approaches to Cancer Invasion and Metastases

1. Preventive or Anticipatory Irradiation

   1. Palliative Radiation in Metastatic Osteosarcoma

      • Joseph R. Castro

      Pages 63-65

   2. Myeloma with Disseminated Osseous Metastases

      • H. Reiter, P. Rubin

      Pages 66-69

   3. Rising Carcinoembryonic Antigen Levels Two Years After Postoperative Irradiation

      • Tyvin A. Rich

      Pages 70-72

2. Re-irradiation

   1. Front Matter

      Pages 73-73

      PDF

   2. Recurrent Rectal Carcinoma Post Radiotherapy

      • Rupert K. Schmidt-Ulrich, Nathan Kaufman

      Pages 75-80

   3. Breast Cancer Re-irradiation

      • Richard D. Pezner

      Pages 81-83

   4. Cauda Equina Syndrome Secondary to Lymphoma

      • William T. Moss

      Pages 84-85

3. Recurrence

   1. Front Matter

      Pages 87-87

      PDF

   2. Chest Wall Recurrence Post Breast Cancer Surgery

      • Robert W. Edland

      Pages 89-90

   3. Aggressive Abdominal Lymphoma

      • Michael J. Miller

      Pages 91-92

   4. Retroperitoneal Recurrence from Anal Canal Carcinoma

      • Sucha O. Asbell

      Pages 93-94

   5. Pelvic Pain

      • Bernard S. Aron

      Pages 95-96

   6. Lumbar Pain Post Nephrectomy

      • Chahin M. Chahbazian

      Pages 97-97

   7. Bone Metastases Post Breast Cancer

      • Chahin M. Chahbazian

      Pages 98-98

   8. Leukemic Meningitis

      • Michael Tomé

      Pages 99-100

   9. Extensive Recurrence of Colon Carcinoma

      • David H. Hussey

      Pages 101-102

   10. Local Recurrence from Cancer of the Rectum

       • Wyman A. Bethune

       Pages 103-105

4. Miscellaneous

   1. Front Matter

      Pages 107-107

      PDF

   2. Pelvic Pain

      • Ralph R. Dobelbower, J. A. Battle, S. Gupta

      Pages 109-111

   3. History of Lymphoma with Abnormal Magnetic Resonance Imaging

      • Alan D. Steinfeld, Jay S. Cooper

      Pages 112-115

In the United States in 1993 the American Cancer Society estimated that there were about 1,300,000 new cases of invasive cancer diagnosed. At the time of presentation about 70% of those patients represented limited local regional disease without evidences of distant dissemination. About 30% of the patients had demonstrated metastatic disease at the time of initial diagnosis or about 390,000 patients. Of those patients with local regional disease about 56% would be cured by the best treatment programs including surgery, radiation therapy with or without chemotherapy when given for cure. Therefore, of the 1,300,000 new cases of invasive cancer, about 509,000 would be cured by the best treatments available. However, about 790,000 patients will have metastatic disease as a part of initial presentation or following the completion of definitive treatment. The majority of the patients with metastatic disease will have metastases to bone as the dominant site of metastatic disease primarily from cancers of the breast and lung but other metastatic sites will be common including lung, liver, mediastinal and retro-peritoneallymph node groups as well as brain and spinal cord. It has been suggested by SMITHERS, CARLING and WINDEYER that the management of the patient with metastatic disease or recurrent disease can be a more difficult problem in management than a patient who is treated for cure.

• biopsy
• brain
• breast cancer
• cancer
• computed tomography (CT)
• imaging
• lymphoma
• magnetic resonance imaging (MRI)
• metastasis
• metastatic disease
• oncology
• radiation
• radiology
• radiotherapy
• tomography
• Radiaton Oncology

• Department of Radiation Oncology, Southern California Permanente Medical Group, Los Angeles, USA

  A. Robert Kagan

• Center for Health Sciences, Johnsson Cancer Center, University of California, Los Angeles, Los Angeles, USA

  Richard J. Steckel

Policies and ethics